2008
DOI: 10.1590/s0102-86502008000400013
|View full text |Cite
|
Sign up to set email alerts
|

Rosiglitazone-enriched diet did not protect liver ischemia-reperfusion injury in a rat model

Abstract: PURPOSE: To determine whether rosiglitazone-enriched diet offer protection in a classical model of liver ischemia-reperfusion injury in rats. METHODS: Two days before the experiment, rats were divided into 2 groups: Control Group (n=13) rats fed with standard diet; Rosi Group (n=13): rats fed with a powdered standard diet supplemented with rosiglitazone. The animals were submitted to liver ischemia-reperfusion by clamping the pedicle of median and left anterolateral lobes. After 1 hour of partial hepatic ische… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2013
2013
2014
2014

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 13 publications
0
1
0
1
Order By: Relevance
“…The capacity of the liver to regenerate is an important clinical issue after major hepatectomies and certainly makes the difference between life and death in some cases of postoperative malfunction when the liver remnant is too small or has an impaired regenerative capacity [1][2][3][4][5][6]. In this sense, several approaches have been tested to stimulate liver regeneration after a massive resection and in situations in which the liver remnant may be too small; however, they have produced controversial results [4,5,[7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…The capacity of the liver to regenerate is an important clinical issue after major hepatectomies and certainly makes the difference between life and death in some cases of postoperative malfunction when the liver remnant is too small or has an impaired regenerative capacity [1][2][3][4][5][6]. In this sense, several approaches have been tested to stimulate liver regeneration after a massive resection and in situations in which the liver remnant may be too small; however, they have produced controversial results [4,5,[7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…8 Considerando a importância e gravidade das lesões causadas por I/R, diversas drogas foram testadas com o objetivo de minimizar estes efeitos. 7,29,[31][32][33][34][35][36][37][38][39][40][41][42][43] No cenário das moléculas capazes de interferir no processo deletério de I/R apresenta-se o N2-mercaptopropioniglicina (N2-MPG), um composto tiólico sintético, que exerce efeitos benéficos contra as lesões de reperfusão através de suas propriedades varredoras de radicais livres. 14,30 O efeito protetor do N2-MPG já foi testado com sucesso em I/R em ratos com hipertrofia cardíaca 14 , em enxertos cutâneos de ratos 15 , pancreatite aguda experimental 16 , e isquemia e reperfusão hepática em ratos 7…”
Section: Discussionunclassified